LoginCreate an account

     
 
Home mySSlife Health FDA probes heart problems with asthma drug Xolair

FDA probes heart problems with asthma drug Xolair

E-mail Print PDF

WASHINGTON (AP) ‚  Federal regulators are reviewing data that suggest the asthma medication Xolair can cause heart attacks, strokes and other potentially deadly problems.

The Food and Drug Administration says preliminary results from a study of 5,000 patients taking the drug suggests an increased risk of heart problems and stroke. The drug's manufacturer Genentech, a unit of Swiss pharmaceutical giant Roche, designed the study to track the long-term safety of the drug over five years.

A representative for Genentech says final results are not expected until 2012. The South San Francisco-based company says it will continue gathering safety information about Xolair.

The FDA says patients should continue taking the drug as directed.


Copyright 2009 The Associated Press.

 

 

 

Search...

WebSite

mySSnews Login



User Menu